World Congestive Heart Failure (CHF) Treatment Devices Market Is Expected to Reach $14.8 Billion by 2022

News provided by

May 19, 2016, 08:30 ET

PORTLAND, Oregon, May 19, 2016 /PRNewswire/ --

Allied Market Research Logo (PRNewsFoto/ALLIED MARKET RESEARCH)

A new report published by Allied Market Research titled, World Congestive Heart Failure (CHF) Treatment Devices Market - Opportunities and Forecasts, 2015 -2022, projects that the world CHF treatment devices market would reach $14.8 billion by 2022, at a CAGR of 5.5% from 2016 to 2022. Implantable cardioverter-defibrillator (ICDs) segment is expected to dominate the world CHF treatment devices market throughout the forecast period. North America is projected to continue its lead in terms of revenue, accounting for more than two-fifths share of the world CHF treatment devices.

(Logo: http://photos.prnewswire.com/prnh/20140911/647229 )

To know more about the report, visit the website at https://www.alliedmarketresearch.com/congestive-heart-failure-treatment-devices-market

The major factors boosting the market growth include the growing incidence of heart failures, technological advancements in CHF treatment devices, and increasing adoption rates for these devices. In addition, rising incidence of diabetes, atherosclerosis, strokes, hypertension, and others due to faulty lifestyle habits such as unhealthy dietary habits, lack of physical activity, and smoking, among others are the leading causes of congestive heart failure. Rising geriatric population base is expected to fuel the prevalence of congestive heart failures thereby augmenting the market growth. Presence of huge unmet medical needs and rising emphasis on early intervention and primary prevention of heart failures are also anticipated to drive the demand for these devices. However, high cost of these devices and unfavorable reimbursement scenario in the emerging countries are some of the factors that restrict the market growth.

The Implantable Cardioverter Defibrillators (ICDs) segment would maintain its lead in the market throughout the analysis period, primarily because of the increasing number of patients with faster-than-normal rhythm as the mean age of the global population is shifting towards older age groups. Ventricular assist devices (VADs) has emerged as the fastest growing segment, with a CAGR of 11.9%. Increasing focus on the development of advanced VDAs and miniaturization of VADs are the major factors responsible for the growth of this market.

Key findings of the study:

In 2015, ICDs accounted for almost one-third of the overall market revenue, and is projected to grow at a CAGR of 4.8% during the forecast period.
The VADs segment is likely to grow at a remarkable CAGR of 11.9%, owing to the innovation and miniaturization of devices.
North America accounted for over 40% share of the world CHF treatment devices market in 2015.
The U.S. is projected to maintain its lead in the world CHF treatment devices market until 2022.
China and Japan are the major shareholders in the Asia-Pacific region, jointly accounting for almost half of share in the Asia-Pacific market.

Geographically, North America accounted for the majority of the share in the world CHF treatment devices market in 2015, and is expected to maintain this lead throughout the forecast period. This was mainly attributed to the increasing incidence of heart failures, presence of highly sophisticated healthcare infrastructure, and adoption of advanced CHF treatment devices in the North American countries. However, Asia-Pacific is expected to be the fastest growing region throughout the analysis period, owing to ample growth opportunities in terms of unmet medical needs for the treatment of cardiac disorders in these regions.

The key players profiled include Abiomed, Inc., Berlin Heart GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, HeartWare International, Inc., Jarvik Heart, Inc., LivaNova PLC, Medtronic plc, ReliantHeart Inc., and St. Jude Medical, Inc.

Similar reports published by Allied Market Research -

World Cardiovascular Surgical Devices and Technologies Market - The global surgical device market is the parent market for cardiovascular devices, which was valued at $240 billion in 2013. Increase in incidence for heart related problems are mainly due to changes in life style. This life style changes has increased the rate of heart surgeries. The U.S. is the leading market for cardiovascular surgical devices due to increase in aging population that is suffering from cardiovascular problems.

To know more about the Cardiovascular Surgical Devices and Technologies Market report, visit the website at https://www.alliedmarketresearch.com/cardiovascular-surgical-devices-and-technologies-market

Heart Blocks Treatment Market - Presently, the heart blocks treatment market is witnessing the lucrative growth rate owing to the rising prevalence of heart diseases coupled with improvements in the various healthcare facilities globally.

To Know more about the heart blocks treatment market report, visit the website at https://www.alliedmarketresearch.com/heart-blocks-treatment-market

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Sona Padmanabhan
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Int'l: +1-503-894-6022
Toll Free: + 1-800-792-5285 (U.S. & Canada)
E-mail: [email protected]